Arrowhead Research Corporation CEO Comments on Recent Nasdaq Letter

February 18, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation’s (NASDAQ:ARWR) (“the Company”) President and Chief Executive Officer today issued the following open letter to the Company’s shareholders:

Twitter
LinkedIn
Facebook
Email
Print

Arrowhead Pharmaceuticals, Inc.